Point-of-sale Naloxone: Novel Community-based Research to Identify Naloxone Availability

West J Emerg Med. 2020 Aug 24;21(5):1188-1194. doi: 10.5811/westjem.7.2020.47252.

Abstract

Introduction: Expanding naloxone availability is important to reduce opioid-related deaths. Recent data suggest low, variable urban naloxone availability. No reports describe naloxone availability at the point of sale (POSN). We characterize POSN without prescription across a Midwestern metropolitan area, via a unique poison center-based study.

Methods: Pharmacies were randomly sampled within a seven-county metropolitan area, geospatially mapped, and distributed among seven investigators, who visited pharmacies and asked, "May I purchase naloxone here without a prescription from my doctor?" Following "No," investigators asked, "Are you aware of the state statute that allows you to dispense naloxone to the public under a standing order?" Materials describing statutory support for POSN were provided. Responses were uploaded to REDCap in real time. We excluded specialty (veterinary, mail order, or infusion) pharmacies a priori. POSN availability is presented as descriptive statistics; characteristics of individual sites associated with POSN availability are reported.

Results: In total, 150 pharmacies were prospectively randomized, with 52 subsequently excluded or unavailable for survey. Thus, 98 were included in the final analysis. POSN was available at 71 (72.5%) of 98 pharmacies. POSN availability was more likely at chain than independent pharmacies (84.7% vs 38.5%, p<0.001); rural areas were more commonly served by independent than chain pharmacies (47.4% vs 21.5%, p = 0.022). Five chain and five independent pharmacies (18.5% each) were unaware of state statutory support for collaborative POSN agreements. Statutory awareness was similar between independent and chain pharmacies (68.8% vs 54.6%, p = 0.453). Rationale for no POSN varied.

Conclusion: POSN is widely available in this metropolitan area. Variability exists between chain and independent pharmacies, and among pharmacies of the same chain; awareness of statutory guidance does not. Poison centers can act to define local POSN availability via direct inquiry in their communities.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Community Pharmacy Services / organization & administration
  • Community Pharmacy Services / standards
  • Female
  • Health Services Accessibility* / organization & administration
  • Health Services Accessibility* / standards
  • Health Services Accessibility* / statistics & numerical data
  • Health Services Needs and Demand
  • Humans
  • Male
  • Naloxone* / supply & distribution
  • Naloxone* / therapeutic use
  • Narcotic Antagonists / supply & distribution
  • Narcotic Antagonists / therapeutic use
  • Opioid-Related Disorders / drug therapy*
  • Pharmacies* / classification
  • Pharmacies* / statistics & numerical data
  • Rural Health
  • Surveys and Questionnaires
  • Urban Health

Substances

  • Narcotic Antagonists
  • Naloxone